Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Todd

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Vaccines|June 27, 2025
SARS-CoV-2 Receptor Binding Domain (RBD) Protein-Protein Conjugate Induces Similar or Better Antibody Responses as Spike mRNA in Rhesus MacaquesPuthupparampil V Scaria, Christopher G Rowe, Ivan Kosik, et al.
Science Translational Medicine|July 4, 2014
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptorAmarendra Pegu, Zhi-yong Yang, Jeffrey C Boyington, et al.
Plos Pathogens|September 22, 2023
Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirusLi Ou, Steven J Chen, I-Ting Teng, et al.
Nature|August 15, 2014
Enhanced neonatal Fc receptor function improves protection against primate SHIV infectionSung-Youl Ko, Amarendra Pegu, Rebecca S Rudicell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2021
Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responsesGuillaume B E Stewart-Jones, Jason Gorman, Li Ou, et al.
Journal of Virology|June 5, 2015
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus InfectionKevin O Saunders, Lingshu Wang, M Gordon Joyce, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Cell Reports|May 31, 2024
Cholesterol reduction by immunization with a PCSK9 mimicBaoshan Zhang, Gwo-Yu Chuang, Andrea Biju, et al.
Nature|July 22, 2014
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progressionNetanya G Sandler, Steven E Bosinger, Jacob D Estes, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Vaccines|June 27, 2025
SARS-CoV-2 Receptor Binding Domain (RBD) Protein-Protein Conjugate Induces Similar or Better Antibody Responses as Spike mRNA in Rhesus MacaquesPuthupparampil V Scaria, Christopher G Rowe, Ivan Kosik, et al.
Science Translational Medicine|July 4, 2014
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptorAmarendra Pegu, Zhi-yong Yang, Jeffrey C Boyington, et al.
Plos Pathogens|September 22, 2023
Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirusLi Ou, Steven J Chen, I-Ting Teng, et al.
Nature|August 15, 2014
Enhanced neonatal Fc receptor function improves protection against primate SHIV infectionSung-Youl Ko, Amarendra Pegu, Rebecca S Rudicell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2021
Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responsesGuillaume B E Stewart-Jones, Jason Gorman, Li Ou, et al.
Journal of Virology|June 5, 2015
Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus InfectionKevin O Saunders, Lingshu Wang, M Gordon Joyce, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variantsHannah A D King, Daniel Brammer, Eric Lewitus, et al.
Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.
Cell Reports|May 31, 2024
Cholesterol reduction by immunization with a PCSK9 mimicBaoshan Zhang, Gwo-Yu Chuang, Andrea Biju, et al.
Nature|July 22, 2014
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progressionNetanya G Sandler, Steven E Bosinger, Jacob D Estes, et al.
Pageof 6